Maxcyte (MXCT) Treasury Shares (2022 - 2025)

Maxcyte (MXCT) has 4 years of Treasury Shares data on file, last reported at $1.8 million in Q4 2025.

• Quarterly Treasury Shares rose 5.97% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (up 5.97% YoY) and the FY2025 annual result came in at $1.8 million, up 5.97% from the prior year.
• Treasury Shares grew to $1.8 million in Q4 2025 per MXCT's latest filing, from $1.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.8 million in Q4 2025 and bottomed at $643600.0 in Q4 2022.
• The 4-year median for Treasury Shares is $1.5 million (2023), against an average of $1.4 million.
• The widest annual swing landed in 2023, when Treasury Shares jumped 101.4%; it then climbed 5.97% in 2025.
• Tracing MXCT's Treasury Shares over 4 years: stood at $643600.0 in 2022, then surged by 101.4% to $1.3 million in 2023, then soared by 31.47% to $1.7 million in 2024, then grew by 5.97% to $1.8 million in 2025.
• Per Business Quant, the three latest MXCT Treasury Shares figures stand at $1.8 million (Q4 2025), $1.7 million (Q4 2024), and $1.3 million (Q4 2023).

Peer Comparison